Why is this medication prescribed?
Ruxolitinib is used to treat myelofibrosis (a condition in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Ruxolitinib is in a class of medications called kinase inhibitors. It works by blocking an enzyme that causes scar tissue to form in the bone marrow.
National Library of Medicine | National Institutes of Health | Department of Health and Human Services
